Clinical Trial Update: Observational Registry Study of Renal Transplant Patients

View source ↗

Summary

Observational registry study of renal transplant patients sponsored by Novartis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Kidney Transplant | Status: WITHDRAWN